Lei Yu

4.0k total citations
104 papers, 2.7k citations indexed

About

Lei Yu is a scholar working on Oncology, Molecular Biology and Biomaterials. According to data from OpenAlex, Lei Yu has authored 104 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 32 papers in Molecular Biology and 23 papers in Biomaterials. Recurrent topics in Lei Yu's work include CAR-T cell therapy research (45 papers), Nanoparticle-Based Drug Delivery (23 papers) and RNA Interference and Gene Delivery (13 papers). Lei Yu is often cited by papers focused on CAR-T cell therapy research (45 papers), Nanoparticle-Based Drug Delivery (23 papers) and RNA Interference and Gene Delivery (13 papers). Lei Yu collaborates with scholars based in China, United States and Taiwan. Lei Yu's co-authors include Zhiqiang Yan, Yi‐Ting Wang, Liqing Kang, Lipeng Gao, Sang Van, Nan Xu, Jinge Zhou, Ke Ding, Xiaoyun Lu and Depei Wu and has published in prestigious journals such as Blood, ACS Nano and Biomaterials.

In The Last Decade

Lei Yu

97 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lei Yu China	32	1.1k	982	663	495	460	104	2.7k
Tracy R. Daniels‐Wells United States	26	1.5k 1.3×	553 0.6×	454 0.7×	644 1.3×	494 1.1×	51	3.0k
James O. Park United States	28	909 0.8×	722 0.7×	617 0.9×	422 0.9×	205 0.4×	92	2.6k
Kun Cheng United States	36	2.5k 2.2×	872 0.9×	684 1.0×	698 1.4×	506 1.1×	102	4.4k
Yajun Guo China	32	1.6k 1.5×	586 0.6×	373 0.6×	507 1.0×	709 1.5×	99	3.0k
Xiao Zhao China	21	1.3k 1.1×	471 0.5×	533 0.8×	446 0.9×	413 0.9×	53	2.7k
Lixia Yu China	33	1.7k 1.5×	859 0.9×	688 1.0×	752 1.5×	431 0.9×	145	3.3k
Junhua Mai United States	25	1.1k 1.0×	534 0.5×	595 0.9×	472 1.0×	554 1.2×	58	2.1k
Behzad Baradaran Iran	28	1.4k 1.2×	757 0.8×	773 1.2×	360 0.7×	659 1.4×	113	2.9k
Joseph A. Reddy United States	30	1.5k 1.3×	763 0.8×	472 0.7×	764 1.5×	150 0.3×	49	2.9k

Countries citing papers authored by Lei Yu

Since Specialization

Citations

This map shows the geographic impact of Lei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Yu more than expected).

Fields of papers citing papers by Lei Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Yu. The network helps show where Lei Yu may publish in the future.

Co-authorship network of co-authors of Lei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Yu. A scholar is included among the top collaborators of Lei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Yu. Lei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Bing, et al.. (2025). Improving domain generalization via enhanced style transfer incorporating PCA. Pattern Recognition. 171. 112171–112171. 1 indexed citations

Yu, Lei, D. Y. Guo, Wei Peng, et al.. (2024). CNN-based track reconstruction study for gamma-ray pair telescope. Astronomy and Computing. 48. 100834–100834.

Xu, Nan, et al.. (2024). BERT-siRNA: siRNA target prediction based on BERT pre-trained interpretable model. Gene. 910. 148330–148330. 3 indexed citations

Yu, Lei, et al.. (2024). A remaining useful life prediction method for rotating machinery based on interactive BiLSTM. Measurement Science and Technology. 36(1). 16128–16128.

Fu, Chengcheng, Lingzhi Yan, Zhi Yan, et al.. (2024). 5-Year Follow-up of Combined Infusion of Anti-CD19 and Anti-BCMA CAR-T after ASCT for High-Risk Newly Diagnosed Multiple Myeloma. Blood. 144(Supplement 1). 4766–4766.

Li, Yangzi, Qingya Cui, Lingling Liu, et al.. (2024). Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion. Cellular Oncology. 47(5). 1649–1661. 4 indexed citations

Wang, Xiangyu, et al.. (2023). Tandem bispecific CD123/CLL‐1 CAR‐T cells exhibit specific cytolytic effector functions against human acute myeloid leukaemia. European Journal Of Haematology. 112(1). 83–93. 15 indexed citations

Xu, Nan, Jingwen Tan, Weixin Xie, et al.. (2022). ILGBMSH: an interpretable classification model for the shRNA target prediction with ensemble learning algorithm. Briefings in Bioinformatics. 23(6). 12 indexed citations

Liu, Rui, Qian Cheng, Liqing Kang, et al.. (2022). CD19 or CD20 CAR T Cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with Central Nervous System Lymphoma. Human Gene Therapy. 33(5-6). 318–329. 17 indexed citations

10.

Wei, Zhenyu, Nan Xu, Liqing Kang, et al.. (2022). Investigation of CRS-associated cytokines in CAR-T therapy with meta-GNN and pathway crosstalk. BMC Bioinformatics. 23(1). 373–373. 10 indexed citations

11.

Liu, Jingjing, Nan Xu, Xinyu Wang, et al.. (2021). Quantitative radio-thin-layer chromatography and positron emission tomography studies for measuring streptavidin transduced chimeric antigen receptor T cells. Journal of Chromatography B. 1182. 122944–122944. 4 indexed citations

12.

Wang, Yeying, Yang Liu, Jinge Zhou, et al.. (2021). Controllable hydrogen release for gas-assisted chemotherapy and ultrasonic imaging of drug-resistant tumors. Chemical Engineering Journal. 421. 129917–129917. 29 indexed citations

13.

Zhang, Ying, Jiaqi Li, Xiaoyan Lou, et al.. (2021). A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma. Frontiers in Oncology. 11. 664421–664421. 35 indexed citations

14.

Kang, Liqing, Xiaowen Tang, Jian Zhang, et al.. (2020). Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes. Experimental Hematology and Oncology. 9(1). 11–11. 49 indexed citations

15.

Kang, Liqing, Xiaowen Tang, Nan Xu, et al.. (2019). shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia. Blood. 134(Supplement_1). 2621–2621. 2 indexed citations

16.

Liu, Yang, Jing Wang, Yi‐Ting Wang, et al.. (2018). Nanocrystal Technology as a Strategy to Improve Drug Bioavailability and Antitumor Efficacy for the Cancer Treatment. Current Pharmaceutical Design. 24(21). 2416–2424. 30 indexed citations

17.

Zhang, Zhang, Jian Zou, Lei Yu, et al.. (2018). YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR^{L858R, T790M}‐mutant resistance in vitro and in vivo. Cancer Medicine. 7(4). 1430–1439. 3 indexed citations

18.

Zhu, Bing, Lei Yu, Wei Hu, et al.. (2018). Inhibition of Autophagy with Chloroquine Enhanced Sinoporphyrin Sodium Mediated Photodynamic Therapy-induced Apoptosis in Human Colorectal Cancer Cells. International Journal of Biological Sciences. 15(1). 12–23. 32 indexed citations

19.

Luo, Zimiao, Kai Jin, Qiang Pang, et al.. (2017). On-Demand Drug Release from Dual-Targeting Small Nanoparticles Triggered by High-Intensity Focused Ultrasound Enhanced Glioblastoma-Targeting Therapy. ACS Applied Materials & Interfaces. 9(37). 31612–31625. 83 indexed citations

20.

Yang, Fei, Yinxiang Wei, Lei Yu, et al.. (2014). Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling. Cellular and Molecular Immunology. 12(1). 66–76. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact